Introduction {#Sec1}
============

Pelvic organ prolapse (POP) is a common multifactorial disease with known risk factors and unclear pathogenesis. POP is characterized by weakening of the pelvic floor and is associated with serious inconveniences and reduced quality of life (QOL) in almost 50 % of women \>50 years of age. Conservative therapies are not always possible or sufficient, and reconstructive surgery with native tissue has high failure rates. Of all treated patients, 30 % will experience recurrent POP within the first 2 years of treatment \[[@CR1], [@CR2]\]. In the 1970s, urogynecologists began using polymeric mesh, originally designed to treat inguinal hernia, in an attempt to restore tissue support in POP patients. However, complications such as mesh contraction, exposure, or extrusion caused such serious health problems that in July 2011, the US Food and Drug Administration (FDA) issued a safety communication about the use of transvaginal mesh in POP repair \[[@CR3], [@CR4]\]. Thus, improved therapies are urgently needed but their development are, however, hampered by a lack of understanding of the pathophysiology of the disease, along with sparse knowledge of the cause--effect relationships of mesh failure in patient tissue \[[@CR5], [@CR6]\].

In recent years, there has been a growing interest in studying tissue composition of patients with prolapse. Researchers have mainly focused on characterizing the extracellular matrix (ECM) of connective tissue that support the pelvic floor, such as the vaginal wall \[[@CR2], [@CR7]--[@CR11]\], the uterosacral ligaments \[[@CR12], [@CR13]\], and the pubocervical fascia \[[@CR13], [@CR14]\]. Different outcomes have been reported, but the overall consensus is that the connective tissue of the vaginal wall is abnormal in women with POP \[[@CR15]\]. The vaginal wall is one of the soft tissues that is constantly being remodelled so it can withstand the different forces applied to it during a woman's lifetime. Thus, weakening of the pelvic floor could be caused by an imbalance in its remodelling \[[@CR2], [@CR7], [@CR8]\]. The presence of artificial substrates may very well influence this process.

Tissue remodelling is a well-balanced process involving several factors with different roles, with cells as modulators. In the vaginal wall, fibroblasts are mechanosensitive cells responsible for maintaining ECM homeostasis. They produce molecules and control anabolic and catabolic processes to remodel their surrounding matrix in response to mechanical and biochemical stimuli. Compounds particularly involved in ECM homeostasis include collagens (mainly types I and III), collagen-degrading matrix metalloproteinases (MMPs), and tissue inhibitors of metalloproteinases (TIMPs). MMPs are involved in both normal and pathological ECM remodelling processes throughout the body, including the pelvic floor. It has been shown that the amounts of active MMP-2 \[[@CR12], [@CR13], [@CR16]\] and/or MMP-9 \[[@CR7], [@CR17]\] are increased in tissue from patients with POP in comparison with controls. However, we were interested to see whether these MMPs are also increased when cells are exposed to cyclic mechanical loading. Furthermore, the question remains whether this enzymatic activity is affected by the presence of artificial polymeric substrates.

In order to answer these questions, our study was designed to evaluate in vitro dynamic cell--matrix interactions that are important for understanding the pathophysiology of and treatments for POP. We hypothesized that fibroblasts from women with different degrees of prolapse display different mechanoresponses depending on the substrate encountered. This hypothesis was tested by subjecting fibroblasts from healthy women and those with mild or severe POP to cyclic mechanical loading mimicking continuous respiration \[[@CR18]\] on artificial polymeric membranes both uncoated and coated with collagen I. Changes in morphology and anabolic/catabolic compounds that may affect remodelling of the ECM were analyzed.

Materials and methods {#Sec2}
=====================

Patient selection, tissue processing, and cell culture {#Sec3}
------------------------------------------------------

Retrieval of biopsies was approved by the medical ethics committees of two hospitals in The Netherlands: VU University Medical Centre (Amsterdam) and Kennemer Gasthuis Hospital (Haarlem), and informed consent was obtained from all participants. Full-thickness biopsies (1 cm^2^) of the anterior vaginal wall were obtained during vaginal hysterectomy of one patient with mild \[POP Quantification (POP-Q) system, stage II\] and one patient with severe POP (POP-Q stage IV). A third woman, who was operated for benign gynecological reasons, was selected as a healthy control. For ethical reasons, the biopsy site of the latter patient was the precervical region of the anterior vaginal wall. Tissues were collected in phosphate-buffered saline (PBS) at 4 °C, and cells were isolated within 24 h under sterile conditions. Fascia was scraped, cut into little pieces, and digested with Liberase TM (final concentration 0.3 U/ml; Roche Diagnostics, Mannheim, Germany) for 3 h at 37 °C and constant agitation. After filtration with a 100-μm cell strainer (BD Falcon, Franklin Lakes, NJ, USA), the pellet was resuspended in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 % fetal bovine serum (FBS), 100 U/ml penicillin, 100 μg/ml streptomycin, and 250 μg/ml amphotericin-B. FBS was obtained from HyClone (South Logan, UT, USA); the other culture components were obtained from Gibco-Life Technologies (Paisley, UK) and Sigma (St. Louis, MO, USA). Subsequently, cells were seeded on six-well plates and grown in an incubator at 37 °C, 95 % humidity, and 5 % carbon dioxide (CO~2~) until they reached 60 % confluence. At that point, the cells were considered to be at passage 0. Fibroblasts from passage 3--5 were used for loading experiments.

Cyclic mechanical loading {#Sec4}
-------------------------

Forty-eight hours before mechanical loading, fibroblasts were seeded at a density of 150,000 cells/well on two artificial polymer substrates: six-well uncoated or collagen I-coated silicone Bioflex® plates (BioFlex, Flexcell International Corp., McKeesport, PA, USA). Just before loading, the cells were refreshed using culture media containing 1 % FBS. The loading regime was applied using a Flexercell FX4000 system (Flexcell) and consisted of 24 or 48 h of continuous cyclic mechanical loading (CML) mimicking continuous respiration, as described by Blaauboer and colleagues \[[@CR18]\] (parameters: sinusoidal wave, frequency 0.2 Hz, and maximum elongation 10 %). The Flexercell device is widely used and has a vacuum pump that pulls down the elastic membrane of the bioflex plates, stretching the cells that are seeded on top accordingly. Fibroblasts cultured under the same conditions but without loading served as static controls. After the loading period, the cells were imaged using the bright field of an inverted Leica DMIL microscope with a DFC320 digital camera (Leica Microsystems, Wetzlar, Germany), and samples were collected for F-actin staining, MMP activity, protein content, and gene expression.

F-actin staining {#Sec5}
----------------

For immunocytochemical staining of F-actin, cells were fixed using 4 % formaldehyde, stained for F-actin with Alexa Fluor 488 phalloidin (Molecular Probes, Leiden, The Netherlands), and imaged using an inverted Leica DMIL microscope (Leica Microsystems), as previously described \[[@CR19]\].

Enzymatic activity {#Sec6}
------------------

After mechanical loading, conditioned media was collected, and the gelatinolytic activity of MMP-2 and MMP-9 was evaluated by zymography using 10 % Novex zymogram gelatin gel (Life Technologies) following manufacturers' protocol. Dark bands of gelatinolytic activity were visualized using an eStain protein staining device (GeneScript, Piscataway, NJ, USA). Images were acquired with Biospectrum AC Imaging System (UVP, Cambridge, UK), and zymogram quantification of band density was performed using Image J 1.44p software (National Institutes of Health, USA). Quantitative data was normalized to total protein content (see below).

Western blot analysis {#Sec7}
---------------------

Conditioned media after 48 h of loading were used to detect protein levels of TIMP-2 by Western blot. Samples were concentrated 2x by freeze drying, denatured for 5 min, and reduced with dithiothreitol. Samples were separated by electrophoresis on a NuPAGE® Novex 4--12 % Bis-Tris gel and transferred to iBlot® polyvinylidene fluoride (PVDF) membrane (Life Technologies). For protein detection, monoclonal antibody anti-TIMP-2 mouse (mAb T2-101; Calbiochem®, Merck Millipore, Darmstadt, Germany) was used at a concentration of 1:500. Blots were blocked for 1 h at room temperature with a blocking buffer \[PBS with 0.5 % Tween-20 and 1 % bovine serum albumin (BSA)\], then incubated with primary antibody in blocking buffer for 1 h at room temperature, followed by overnight incubation at 4 °C. Bound antibodies were visualized with a horseradish peroxidase-conjugated antibody goat anti-mouse (1:10,000) and Supersignal West Pico Chemiluminescent kit (Thermo Scientific, Rockford, IL, USA). Images were acquired with Biospectrum AC Imaging System (UVP), and quantification of band density was performed using Image J 1.44p software (NIH).

Total protein quantification {#Sec8}
----------------------------

For total protein quantification, cells were lysed in buffer containing 50 mM Tris, pH 7.5, 150 mM sodium chloride (NaCl), 1mM sodium orthovanadate, 1 % Nonidet P-40, 0.1 % sodium deoxycholate, and ethylenediaminetetraacetate (EDTA)-free protease inhibitor mixture (Sigma-Aldrich). Total protein content was determined using Pierce BCA Protein Assay kit (Thermo Scientific) following the supplier's specifications. Quantification was performed spectrophotometrically between 540--590 nm and using a 1,420 multilabel counter VICTOR^2^ (WALLAC, Turku, Finland).

Gene expression {#Sec9}
---------------

For gene expression, cells were lysed in a solution (1:100) of β-mercaptoethanol (Sigma-Aldrich) and RA1 buffer (Macherey-Nagel, Bioke, Leiden, The Netherlands). According to the manufacturers' instructions, total RNA was isolated using NucleoSpin TriPrep kit (Bioke) to a final concentration of 250 ng/ml and was reverse transcribed using SuperScript VILO complementary DNA (cDNA) synthesis kit (Life Technologies). Gene expression of alpha-1(I)procollagen (*Col1a1*), alpha-1(III)procollagen (*Col3a1*), matrix metalloproteinase-2 (*MMP-2*), *TIMP-2*, and the housekeeping genes tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (*Ywhaz*) and human ubiquitin C (*hUBC*) were evaluated using the primers listed in Table [1](#Tab1){ref-type="table"} (Life Technologies), the SYBR Green Reaction Kit following suppliers' specifications (Roche), and measured by reverse transcription polymerase chain reaction (RT-PCR) in a Light Cycler 480 device (Roche). Gene expression levels were normalized using a factor derived from the equation √(*Ywhaz x hUBC*). Crossing points were assessed using the Light Cycler software (version 4) and plotted versus serial dilutions of cDNA derived from a human universal reference total RNA (Clontech Laboratories Palo Alto, CA, USA).Table 1Primer sequences used for reverse transcriptase polymerase chain reaction (RT-PCR)Target geneOligonucleotide sequenceAnnealing temperature (°C)Product size (bp)*Col1a1*Forward reverse5′ TCCAACGAGATCGAGATCC 3′571915′ AAGCCGAATTCCTGGTCT 3′*Col3a1*Forward reverse5′ GATCCGTTCTCTGCGATGAC 3′562795′ AGTTCTGAGGACCAGTAGGG 3′*MMP-2*Forward reverse5′ GGCAGTGCAATACCTGAACA 3′562535′ AGGTGTGTAGCCAATGATCCT 3′*TIMP-2*Forward reverse5′ CTGAACCACAGGTACCAGAT 3′632375′ TGCTTATGGGTCCTCGATG 3′*Ywhaz*Forward reverse5′ GATGAAGCCATTGCTGAACTTG 3′562295′ CTATTTGTGGGACAGCATGGA 3′*hUBC*Forward reverse5′ GCGGTGAACGCCGATGATTAT 3′562025′ TTTGCCTTGACATTCTCGATGG 3′*Col1a1* alpha-1(I)procollagen, *Col3a1* alpha-1(III)procollagen, *MMP-2* matrix metalloproteinase-2, *TIMP-2* tissue inhibitor of metalloproteinases-2, *hUBC* human ubiquitin C, *Ywhaz* tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide

Statistical analysis {#Sec10}
--------------------

Three independent experiments were performed in duplicate, and data are expressed as mean ± standard deviation (SD). Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by Tukey--Kramer's post hoc test (Prism version 5.02, GraphPad Software Inc., La Jolla, CA, USA). Differences were considered significant at the 5 % level (*p* \< 0.05).

Results {#Sec11}
=======

After 48 h of cyclic mechanical loading, morphological analysis showed cell alignment perpendicular to the force that was facilitated by collagen-coated surfaces, with no apparent differences between healthy (Fig. [1b and d](#Fig1){ref-type="fig"}) and POP (Fig. [2c and d](#Fig2){ref-type="fig"}) fibroblasts. At an earlier time point (24 h), load-induced rearrangement of F-actin fibers was completed for mild but not severe POP fibroblasts (Fig. [2a vs. b](#Fig2){ref-type="fig"}). Static control cells displayed random distribution independent of surface (Fig. [1a and b](#Fig1){ref-type="fig"}).Fig. 1Cell attachment and alignment is facilitated by collagen I substrates. Representative images of healthy fibroblasts after 48 h of cyclic mechanical loading (CML) on uncoated (**a**, **c**) or collagen-I-coated (**b**, **d**) plates. Morphology shows random cell distribution under static conditions (−CML, **a** and **b**); whereas stretching induced cell alignment perpendicular to the force (*F*), especially on collagen-I-coated plates (+CML, **c** and **d**). Images were acquired with 10x objective of a Leica microscope, bar is 100 μmFig. 2On collagen-I-coated plates, rearrangement of F-actin fibers was completed after 24 h of loading for mild but not for severe pelvic organ prolapse (POP) fibroblasts. Representative images of POP fibroblasts F-actin fibers showing cell alignment perpendicular to the force (*F*) on collagen-I-coated plates after 24 h (**a** and **b**) or 48 h (**c** and **d**) of loading. F-actin fibers stained with phalloidin *Bar* 100 μm

To evaluate the effects of the different experimental conditions on the capacity of the fibroblasts to remodel the ECM, secreted MMP-2 and MMP-9 enzymatic activity were evaluated at two time points (24 and 48 h). Total levels of released MMP-2 by POP fibroblasts at 24 h were lower than healthy control cells, independent of the surface substrate (Fig. [3a](#Fig3){ref-type="fig"}). At the same time point, but only on uncoated plates, cyclic mechanical loading induced activation of MMP-2, which was more pronounced by healthy fibroblasts. Under static conditions, MMP-2 activation was only observed in healthy control cells on uncoated plates (Fig. [3a](#Fig3){ref-type="fig"} left blot). There was no apparent activation of MMP-2 on collagen-I-coated plates, with the exception of a very faint band of active MMP-2 on stretched mild POP fibroblasts (Fig. [3a](#Fig3){ref-type="fig"} middle blot).Fig. 3Mechanical loading induced activation over time of matrix metalloproteinase-2 (MMP-2) by fibroblasts seeded on uncoated plates. Conditioned media of fibroblasts from healthy, mild, and severe pelvic organ prolapse (POP) patients after 24 h (**a**) or 48 h (**b** and **c**) of cyclic mechanical loading (CML) on uncoated or collagen-I-coated plates was evaluated. Blots **a** and **b** are representative zymograms showing MMP-2 activity; **c** Is a Western blot of conditioned media (concentrated x2), showing that tissue inhibitor of metalloproteinase-2 (TIMP-2) was released by cells on collagen substrates only. Blots at 48 h of CML were analyzed with imageJ, and quantitative data was normalized to total protein content. Quantitative data from zymograms show levels of released pro-MMP-2 by fibroblasts on uncoated (**d**) or collagen I-coated (**e**) plates, and the ratio between active and inactive MMP-2 forms on uncoated plates (**f**). Data represent mean ± standard deviation (SD). \*\**p* \< 0.01 compared with static condition (−CML). Release of TIMP-2 by fibroblasts on collagen substrates (**g**). Low-serum media that was not exposed to cells was used as negative control. Positive controls used: for zymograms, human recombinant MMP-2; for Western blot, cell lysates from dermal stem cells

At a later time point (48 h), levels of released pro-MMP-2 were similar on collagen-I surfaces, and no active MMP-2 was found (Fig. [3b](#Fig3){ref-type="fig"} middle blot). On uncoated plates, stretching of fibroblasts induced MMP-2 activation that increased from 24 to 48 h. Such activation was lower in POP fibroblasts compared with healthy controls (Fig. [3b and b](#Fig3){ref-type="fig"}, left blot). Western blot analysis at 48 h revealed the presence of TIMP-2 only in cells exposed to collagen-coated plates without any apparent regulation by loading (Fig. [3c](#Fig3){ref-type="fig"}). Released MMP-9 was below detection levels.

As levels of released MMP-2 were higher after 48 h, these data were quantified and normalized to total protein content. Quantitative data revealed that under static conditions and regardless of the type of substrate, most cells released similar amounts of pro-MMP-2 into the extracellular environment (Fig. [3d and e](#Fig3){ref-type="fig"}). On uncoated plates, mechanical loading induced MMP-2 activation by all cell populations, as the ratios between active and inactive (pro) MMP-2 forms were always \>1, and ANOVA showed that such an increment was significant only in the case of healthy fibroblasts (*p* \< 0.01) (Fig. [3f](#Fig3){ref-type="fig"}). On collagen-I-coated plates, quantitative data revealed similar expression profiles of pro-MMP-2 and TIMP-2 in all groups (Fig. [3e and g](#Fig3){ref-type="fig"}).

To detect differences at the gene-expression level, ECM-remodelling-related genes *Col1a1*, *Col3a1*, *MMP-2*, and *TIMP-2* were chosen to evaluate the effects of cyclic mechanical loading and surface substrate after 48 h of treatment. On uncoated plates, both mild and severe POP fibroblasts showed significantly lower gene expression of *Col1a1* and *Col3a1* when compared with healthy controls (Fig. [4a and b](#Fig4){ref-type="fig"}). On the same substrate, gene expression of *Col1α1* was down-regulated by mechanical loading in healthy but not in POP fibroblasts. *MMP-2* expression levels were similar in all fibroblasts, independent of loading conditions (Fig. [4c and d](#Fig4){ref-type="fig"}). On collagen-I-coated plates, mild but not severe POP fibroblasts showed lower gene expression levels of *Col1a1*, *Col3a1,* and *MMP-2* when compared with healthy controls (Fig. [4e, f and g](#Fig4){ref-type="fig"}). *TIMP-2* expression levels were similar in all fibroblasts, independent of loading or coating conditions (Fig. [4h](#Fig4){ref-type="fig"}).Fig. 4Relative expression of extracellular matrix (ECM)-remodelling-related genes. Fibroblasts from healthy and mild, or severe pelvic organ prolapse (POP) patients were subjected or not subjected to cyclic mechanical loading (+/−CML) on uncoated (**a**, **b**, **c,** and **d**) or collagen-I-coated (**e**, **f**, **g**, and **h**) plates. Each *column* represents a different gene: *Col1a1* (**a**) and (**e**); *Col3a1* (**b**) and (**f**); *MMP-2* (**c**) and (**g**); *TIMP-2* (**d**) and (**h**). Values are normalized to housekeeping genes (*Ywhaz* and *hUBC*), expressed as a percentage of healthy controls, and represent the mean ± standard deviation (SD). \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001;compared with the *first bar*, unless indicated otherwise

Discussion {#Sec12}
==========

In POP, tissue strength is lost, stiffness is increased \[[@CR9]--[@CR11]\], and ECM quality is compromised \[[@CR15]\]. Consequently, fibroblasts might be exposed to an abnormal matrix. The biomechanical environment may be further compromised if during pelvic reconstructive surgery, stiff, nonresorbable polymeric mesh is used to replace tissue function. We evaluated the possible roles of CML and two surface substrates on the functionality of healthy and mild and severe POP fibroblasts using an in vitro dynamic model. We found variations of fibroblast responses at morphological, enzymatic, and gene-expression levels.

Cells respond to mechanical stimuli by remodelling their actin cytoskeleton \[[@CR20]\]. Our results show that all fibroblasts were mechanoresponsive, as their actin cytoskeleton aligned perpendicular to the force after 48 h of cyclic mechanical loading, especially in the presence of collagen I. This finding is consistent with previous reports that fibroblasts from the pelvic floor completely align after being stretched for 48 h \[[@CR21]\]. Differences between cell populations were seen after 24 h of loading on collagen-I substrates, when visualization of actin filaments revealed that alignment of severe POP fibroblasts appear delayed in comparison with their mild counterparts; also, released MMP-2 was lower in fibroblasts from POP patients compared with healthy control cells. These effects seemed to disappear with time, as after 48 h of stretching, there was no apparent difference in cell alignment, no activation of MMP-2, TIMP-2 protein levels corresponded to pro-MMP-2, and no difference in gene expression of *MMP-2* or *TIMP-2*.

Interestingly, when fibroblasts were exposed to artificial polymeric substrates (uncoated plates), clear differences were seen in production and activation of MMP-2, TIMP-2 could not be detected, and mechanical loading promoted MMP-2 activation over time. After 48 h of loading, MMP-2 activation was significant only in healthy, not in POP, fibroblasts. Moreover, cells from women with prolapse showed differential gene expression of anabolic but not catabolic compounds: collagens I and III were lower in women with POP, and mechanical loading down-regulated collagen I on healthy fibroblasts only. Changes seen with catabolically secreted proteins were not correlated at gene-expression levels. Such discrepancy emphasizes the importance of using different evaluation parameters because changes at gene expression levels do not necessarily reflect changes at protein levels, and they can occur at different times.

Taken together, our data suggest that although fibroblasts from POP patients seem to have lower mechanoresponses, in the presence of collagen-I substrate, the system eventually reaches a balance. This latter finding confirms 48-h data from Zong and colleagues \[[@CR22]\], who used collagen-I-coated plates in their dynamic in vitro model with similar experimental conditions (sinus wave; amplitudes 8 % and 16 %; frequency 1 Hz), and found no differences between healthy and mild and severe POP vaginal fibroblasts. However, it appears that when cells are exposed to artificial polymeric substrates and stress is imposed, this balance is not reached. Fibroblasts from women with POP seem preconditioned by the abnormal prolapsed matrix. Unable to respond in the same way as control cells, POP fibroblasts might not be able to restore ECM homeostasis when artificial polymeric substrates are added to their microenvironment. In such circumstances, tissue remodelling might not be restored but, rather, may in turn provide a negative feedback loop that deteriorates the ECM even further, leading to an additional loss of strength, increased stiffness, and eventually more tissue damage. Such implications at the micro level are in line with findings at the macro level. Several studies report increased stiffness in prolapsed tissues when assessing biomechanical properties of the vaginal wall from patients with POP compared with healthy controls \[[@CR17]--[@CR19]\]. Moreover, it has also been shown that polymeric mesh used in genital prolapse surgery is stiffer than native tissue \[[@CR23]\]. Feola and colleagues \[[@CR24]\] showed correlation between mesh stiffness and tissue deterioration in a nonprimate animal model. Therefore, changes in the vaginal wall at the cellular level could be good indicators of tissue behavior and should be taken into account when using polymeric mesh to treat patients. As surface substrate affects cellular behavior, and cell--matrix interactions seem to be impaired in POP fibroblasts, improving mesh surface characteristics could enhance implant integration.

Conclusions from this study should be treated with care: results were obtained in an in vitro setup, which allowed us to control certain parameters but does not fully reflect the in vivo situation. Furthermore, we are aware that our patient population was too small to draw conclusions about all women with POP. The experiments were repeated three times, all confirming the first results and suggesting our model is valid. We are in the process of expanding our sample size.

To improve pelvic floor treatment, further studies evaluating the effect on fibroblasts of different ECM proteins in dynamic in vitro systems could provide important clues to improve mesh designs before using animals for in vivo studies and humans for clinical trials. This approach should provide better clinical outcomes by using information from bench to bedside to restore pelvic support and improve host--implant integration when treating POP.

In summary, this study provides a model by which to evaluate dynamic interactions of fibroblasts from the pelvic floor with artificial substrates in vitro. Unlike previous models \[[@CR21], [@CR22]\], we chose a continuous physiological stretching regimen to compare fibroblast mechanoresponses to artificial collagen-I-coated and uncoated substrates. We thereby show clear differences between POP and healthy fibroblasts on artificial polymer substrates. This emphasizes the importance of evaluating cell--matrix interactions with different surroundings to better understand the influences in dynamic environments of proteins from the ECM on vaginal fibroblast behavior. Such outcomes may provide important clues for designing biomesh that appropriately mimics the ECM environment, as it seems that the addition of collagen coating helps restore vaginal-wall metabolic balance. This new approach may thus improve treatment for POP.
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